30 results on '"Andrianaivoarimanana, Voahangy"'
Search Results
2. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol
- Author
-
Randremanana, Rindra Vatosoa, Raberahona, Mihaja, de Dieu Randria, Mamy Jean, Bourner, Josephine, Zadonirina, Gabriella, Razananaivo, Hanitra, Mayouya-Gamana, Théodora, Mangahasimbola, Reziky, Pesonel, Elise, Gillesen, Annelies, Rajerison, Minoarisoa, Andrianaivoarimanana, Voahangy, Edwards, Tansy, Horby, Peter, and Olliaro, Piero
- Published
- 2024
- Full Text
- View/download PDF
3. Characterization of Klebsiella pneumoniae isolated from patients suspected of pulmonary or bubonic plague during the Madagascar epidemic in 2017
- Author
-
Rakotondrasoa, Andriniaina, Andrianonimiadana, Lova Maminirina, Rahajandraibe, Soloandry, Razafimahatratra, Solohery, Andrianaivoarimanana, Voahangy, Rahelinirina, Soanandrasana, Crucitti, Tania, Brisse, Sylvain, Jeannoda, Victor, Rajerison, Minoarisoa, and Collard, Jean-Marc
- Published
- 2022
- Full Text
- View/download PDF
4. Review of genotyping methods for Yersinia pestis in Madagascar.
- Author
-
Randriantseheno, Lovasoa Nomena, Andrianaivoarimanana, Voahangy, Pizarro-Cerdá, Javier, Wagner, David M., and Rajerison, Minoarisoa
- Subjects
- *
YERSINIA pestis , *HORIZONTAL gene transfer , *RESTRICTION fragment length polymorphisms , *WHOLE genome sequencing , *RODENT populations , *PARACOCCIDIOIDOMYCOSIS , *TULAREMIA - Abstract
Background: Plague, a zoonotic disease caused by Yersinia pestis, was responsible for 3 historical human pandemics that killed millions of people. It remains endemic in rodent populations in Africa, Asia, North America, and South America but human plague is rare in most of these locations. However, human plague is still highly prevalent in Madagascar, which typically records a significant part of all annual global cases. This has afforded an opportunity to study contemporary human plague in detail using various typing methods for Y. pestis. Aim: This review aims to summarize the methods that have been used to type Y. pestis in Madagascar along with the major discoveries that have been made using these approaches. Methods: Pubmed and Google Scholar were used to search for the keywords: "typing Yersinia pestis Madagascar," "evolution Yersinia pestis Madagascar," and "diversity Yersinia pestis Madagascar." Eleven publications were relevant to our topic and further information was retrieved from references cited in those publications. Results: The history of Y. pestis typing in Madagascar can be divided in 2 periods: the pre-genomics and genomics eras. During the pre-genomics era, ribotyping, direct observation of plasmid content and plasmid restriction fragment length polymorphisms (RFLP) were employed but only revealed a limited amount of diversity among Malagasy Y. pestis strains. Extensive diversity only started to be revealed in the genomics era with the use of clustered regularly interspaced palindromic repeats (CRISPR), multiple-locus variable number tandem repeats (VNTR) analysis (MLVA), and single-nucleotide polymorphisms (SNPs) discovered from whole genome sequences. These higher-resolution genotyping methods have made it possible to highlight the distribution and persistence of genotypes in the different plague foci of Madagascar (Mahajanga and the Central and Northern Highlands) by genotyping strains from the same locations across years, to detect transfers between foci, to date the emergence of genotypes, and even to document the transmission of antimicrobial resistant (AMR) strains during a pneumonic plague outbreak. Despite these discoveries, there still remain topics that deserve to be explored, such as the contribution of horizontal gene transfer to the evolution of Malagasy Y. pestis strains and the evolutionary history of Y. pestis in Madagascar. Conclusions: Genotyping of Y. pestis has yielded important insights on plague in Madagascar, particularly since the advent of whole-genome sequencing (WGS). These include a better understanding of plague persistence in the environment, antimicrobial AMR and multi-drug resistance in Y. pestis, and the person-to-person spread of pneumonic plague. Considering that human plague is still a significant public health threat in Madagascar, these insights can be useful for controlling and preventing human plague in Madagascar and elsewhere, and also are relevant for understanding the historical pandemics and the possible use of Y. pestis as a biological weapon. Author summary: Plague remains a major public health concern in Madagascar and has been since its introduction to the country in 1898. The scale and rapid spread of the 2017 pneumonic plague epidemic in urban settings in Madagascar reminds us of the relevance of improving our understanding of this disease as well as its monitoring. In this review, we revisit the studies conducted in Madagascar that utilized genotyping approaches to understand the evolution, geographic distribution, and emergence of Y. pestis, the etiologic agent of plague. These studies greatly contributed to the comprehension of the origin, the transmission and the dynamics of the circulation of plague in Madagascar, providing useful information for preparing for future plague outbreaks in Madagascar and elsewhere. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Epidemiological characteristics of an urban plague epidemic in Madagascar, August–November, 2017: an outbreak report
- Author
-
Randremanana, Rindra, Andrianaivoarimanana, Voahangy, Nikolay, Birgit, Ramasindrazana, Beza, Paireau, Juliette, ten Bosch, Quirine Astrid, Rakotondramanga, Jean Marius, Rahajandraibe, Soloandry, Rahelinirina, Soanandrasana, Rakotomanana, Fanjasoa, Rakotoarimanana, Feno M, Randriamampionona, Léa Bricette, Razafimbia, Vaoary, De Dieu Randria, Mamy Jean, Raberahona, Mihaja, Mikaty, Guillain, Le Guern, Anne-Sophie, Rakotonjanabelo, Lamina Arthur, Ndiaye, Charlotte Faty, Rasolofo, Voahangy, Bertherat, Eric, Ratsitorahina, Maherisoa, Cauchemez, Simon, Baril, Laurence, Spiegel, André, and Rajerison, Minoarisoa
- Published
- 2019
- Full Text
- View/download PDF
6. Trends of Human Plague, Madagascar, 1998-2016
- Author
-
Andrianaivoarimanana, Voahangy, Piola, Patrice, Wagner, David M., Rakotomanana, Fanjasoa, Maheriniaina, Viviane, Andrianalimanana, Samuel, Chanteau, Suzanne, Rahalison, Lila, Ratsitorahina, Maherisoa, and Rajerison, Minoarisoa
- Subjects
Epidemiology -- Analysis ,Plague -- Patient outcomes ,Zoonoses ,Intelligence gathering ,Medical tests ,Health - Abstract
Plague, caused by the bacterium Yersinia pestis, produced some of the most devastating epidemics in human history; it is endemic to regions of Asia, the Americas, and Africa. Africa accounts [...]
- Published
- 2019
- Full Text
- View/download PDF
7. Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar
- Author
-
Andrianaivoarimanana, Voahangy, Iharisoa, Alice Lantoniaina, Rahalison, Lila, Ralimanantsoa, Marie Laurette, Ratsitorahina, Maherisoa, Rakotonanahary, Rado J. L., Carniel, Elisabeth, Demeure, Christian, and Rajerison, Minoarisoa
- Published
- 2020
- Full Text
- View/download PDF
8. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
- Author
-
Randremanana, Rindra Vatosoa, Raberahona, Mihaja, Randria, Mamy Jean de Dieu, Rajerison, Minoarisoa, Andrianaivoarimanana, Voahangy, Legrand, Agathe, Rasoanaivo, Tsinjo Fehizoro, Randriamparany, Ravaka, Mayouya-Gamana, Théodora, Mangahasimbola, Reziky, Bourner, Josie, Salam, Alex, Gillesen, Annelies, Edwards, Tansy, Schoenhals, Matthieu, Baril, Laurence, Horby, Peter, and Olliaro, Piero
- Published
- 2020
- Full Text
- View/download PDF
9. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar
- Author
-
Rajerison, Minoarisoa, Melocco, Marie, Andrianaivoarimanana, Voahangy, Rahajandraibe, Soloandry, Rakotoarimanana, Feno, Spiegel, André, Ratsitorahina, Maherisoa, and Baril, Laurence
- Published
- 2020
- Full Text
- View/download PDF
10. A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague.
- Author
-
Shattock, Robin John, Andrianaivoarimanana, Voahangy, McKay, Paul F., Randriantseheno, Lovasoa Nomena, Murugaiah, Valarmathy, Samnuan, K., Rogers, Paul, Tregoning, John S., Rajerison, Minoarisoa, Moore, Kristoffer M., Laws, Thomas Robert, and Williamson, E. Diane
- Subjects
YERSINIA pestis ,RNA ,VACCINES ,DISEASE outbreaks ,IMMUNOGLOBULINS ,ANTIGENS - Abstract
Mice were immunized with a combination of self-amplifying (sa) RNA constructs for the F1 and V antigens of Yersinia pestis at a dose level of 1pg or 5pg or with the respective protein sub-units as a reference vaccine. The immunization of outbred OF1 mice on day 0 and day 28 with the lowest dose used (1pg) of each of the saRNA constructs in lipid nanoparticles protected 5/7 mice against subsequent sub-cutaneous challenge on day 56 with 180 cfu (2.8 MLD) of a 2021 clinical isolate of Y. pestis termed 10-21/S whilst 5/7 mice were protected against 1800cfu (28MLD) of the same bacteria on day 56. By comparison, only 1/8 or 1/7 negative control mice immunized with 10 pg of irrelevant haemagglutin RNA in lipid nanoparticles (LNP) survived the challenge with 2.8 MLD or 28 MLD Y. pestis 10-21/S, respectively. BALB/c mice were also immunized with the same saRNA constructs and responded with the secretion of specific IgG to F1 and V, neutralizing antibodies for the V antigen and developed a recall response to both F1 and V. These data represent the first report of an RNA vaccine approach using self-amplifying technology and encoding both of the essential virulence antigens, providing efficacy against Y. pestis. This saRNA vaccine for plague has the potential for further development, particularly since its amplifying nature can induce immunity with less boosting. It is also amenable to rapid manufacture with simpler downstream processing than protein sub-units, enabling rapid deployment and surge manufacture during disease outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Pneumonic plague transmission, Moramanga, Madagascar, 2015
- Author
-
Ramasindrazana, Beza, Andrianaivoarimanana, Voahangy, Rakotondramanga, Jean Marius, Birdsell, Dawn N., Ratsitorahina, Maherisoa, and Rajerison, Minoarisoa
- Subjects
Infection -- Health aspects -- Analysis ,Phylogeny -- Health aspects -- Analysis ,Plague -- Health aspects -- Analysis ,Health - Abstract
Plague, caused by the bacterium Yersinia pestis, is a fleaborne disease responsible for the death of tens of millions of persons throughout history (1,2). The bacterium spread to Madagascar in [...]
- Published
- 2017
- Full Text
- View/download PDF
12. Phylogenetic analysis of the origin and spread of plague in Madagascar.
- Author
-
Esquivel Gomez, Luis Roger, Savin, Cyril, Andrianaivoarimanana, Voahangy, Rahajandraibe, Soloandry, Randriantseheno, Lovasoa Nomena, Zhou, Zhemin, Kocher, Arthur, Didelot, Xavier, Rajerison, Minoarisoa, and Kühnert, Denise
- Subjects
YERSINIA pestis ,ZOONOSES ,COMMUNICABLE diseases ,UPLANDS ,PHYLOGENY - Abstract
Background: Plague is a zoonotic disease caused by the bacterium Yersinia pestis, highly prevalent in the Central Highlands, a mountainous region in the center of Madagascar. After a plague-free period of over 60 years in the northwestern coast city of Mahajanga, the disease reappeared in 1991 and caused several outbreaks until 1999. Previous research indicates that the disease was reintroduced to the city of Mahajanga from the Central Highlands instead of reemerging from a local reservoir. However, it is not clear how many reintroductions occurred and when they took place. Methodology/Principal findings: In this study we applied a Bayesian phylogeographic model to detect and date migrations of Y. pestis between the two locations that could be linked to the re-emergence of plague in Mahajanga. Genome sequences of 300 Y. pestis strains sampled between 1964 and 2012 were analyzed. Four migrations from the Central Highlands to Mahajanga were detected. Two resulted in persistent transmission in humans, one was responsible for most of the human cases recorded between 1995 and 1999, while the other produced plague cases in 1991 and 1992. We dated the emergence of the Y. pestis sub-branch 1.ORI3, which is only present in Madagascar and Turkey, to the beginning of the 20
th century, using a Bayesian molecular dating analysis. The split between 1.ORI3 and its ancestor lineage 1.ORI2 was dated to the second half of the 19th century. Conclusions/Significance: Our results indicate that two independent migrations from the Central Highlands caused the plague outbreaks in Mahajanga during the 1990s, with both introductions occurring during the early 1980s. They happened over a decade before the detection of human cases, thus the pathogen likely survived in wild reservoirs until the spillover to humans was possible. This study demonstrates the value of Bayesian phylogenetics in elucidating the re-emergence of infectious diseases. Author summary: In 1991 human cases of plague were reported in the city of Mahajanga, located in the west coast of Madagascar, after 60 years without human cases. Existing evidence suggests that Yersinia pestis, the causal agent of the disease, was reintroduced to the city from a mountainous region known as the Central Highlands. We performed a phylogeographic analysis on 300 Y. pestis genome sequences to determine how many migrations of the pathogen between the two locations were related to the reappearance of the disease in Mahajanga. The results revealed that two migrations from the Central Highlands were the cause of the outbreaks of plague in the west coast of the country during the 1990s. We also aimed to date the emergence of the Y.pestis variant that circulates in Madagascar and is also present in Turkey. To do this, we conducted a molecular dating analysis using an extended data set of 445 sequences, which contained sequences from Turkey and India (the country from which the pathogen was exported to Madagascar for the first time). The analysis indicated that this particular variant emerged in the first decade of the 20th century. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
13. Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report
- Author
-
Andrianaivoarimanana, Voahangy, Bertherat, Eric, Rajaonarison, Rojo, Rakotondramaro, Tiana, Rogier, Christophe, and Rajerison, Minoarisoa
- Published
- 2018
- Full Text
- View/download PDF
14. Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar.
- Author
-
ten Bosch, Quirine, Andrianaivoarimanana, Voahangy, Ramasindrazana, Beza, Mikaty, Guillain, Rakotonanahary, Rado JL, Nikolay, Birgit, Rahajandraibe, Soloandry, Feher, Maxence, Grassin, Quentin, Paireau, Juliette, Rahelinirina, Soanandrasana, Randremanana, Rindra, Rakotoarimanana, Feno, Melocco, Marie, Rasolofo, Voahangy, Pizarro-Cerda, Javier, Le Guern, Anne-Sophie, Bertherat, Eric, Ratsitorahina, Maherisoa, and Spiegel, André
- Subjects
- *
DIAGNOSIS methods , *EPIDEMICS , *PLAGUE , *SYMPTOMS , *RESOURCE allocation , *MOLECULAR biology - Abstract
During outbreaks, the lack of diagnostic "gold standard" can mask the true burden of infection in the population and hamper the allocation of resources required for control. Here, we present an analytical framework to evaluate and optimize the use of diagnostics when multiple yet imperfect diagnostic tests are available. We apply it to laboratory results of 2,136 samples, analyzed with 3 diagnostic tests (based on up to 7 diagnostic outcomes), collected during the 2017 pneumonic (PP) and bubonic plague (BP) outbreak in Madagascar, which was unprecedented both in the number of notified cases, clinical presentation, and spatial distribution. The extent of these outbreaks has however remained unclear due to nonoptimal assays. Using latent class methods, we estimate that 7% to 15% of notified cases were Yersinia pestis-infected. Overreporting was highest during the peak of the outbreak and lowest in the rural settings endemic to Y. pestis. Molecular biology methods offered the best compromise between sensitivity and specificity. The specificity of the rapid diagnostic test was relatively low (PP: 82%, BP: 85%), particularly for use in contexts with large quantities of misclassified cases. Comparison with data from a subsequent seasonal Y. pestis outbreak in 2018 reveal better test performance (BP: specificity 99%, sensitivity: 91%), indicating that factors related to the response to a large, explosive outbreak may well have affected test performance. We used our framework to optimize the case classification and derive consolidated epidemic trends. Our approach may help reduce uncertainties in other outbreaks where diagnostics are imperfect. The response to the 2017 plague outbreak in Madagascar was complicated by the lack of a perfect or "gold standard" diagnostic. This study shows how multiple, imperfect diagnostic tests can be used to improve the response to an outbreak. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.
- Author
-
Andrianaivoarimanana, Voahangy, Wagner, David M, Birdsell, Dawn N, Nikolay, Birgit, Rakotoarimanana, Faniry, Randriantseheno, Lovasoa N, Vogler, Amy J, Sahl, Jason W, Hall, Carina M, Somprasong, Nawarat, Cauchemez, Simon, Schweizer, Herbert P, Razafimandimby, Harimahefa, Rogier, Christophe, and Rajerison, Minoarisoa
- Subjects
- *
PREVENTION of infectious disease transmission , *PREVENTION of epidemics , *ANTIFUNGAL agents , *GENETIC mutation , *RETROSPECTIVE studies , *GENETIC testing , *PLAGUE , *DRUG resistance in microorganisms , *COMBINED modality therapy , *BACTERIA - Abstract
Background Pneumonic plague (PP), caused by Yersinia pestis , is the most feared clinical form of plague due to its rapid lethality and potential to cause outbreaks. PP outbreaks are now rare due to antimicrobial therapy. Methods A PP outbreak in Madagascar involving transmission of a Y. pestis strain resistant to streptomycin, the current recommended first-line treatment in Madagascar, was retrospectively characterized using epidemiology, clinical diagnostics, molecular characterization, and animal studies. Results The outbreak occurred in February 2013 in the Faratsiho district of Madagascar and involved 22 cases, including 3 untreated fatalities. The 19 other cases participated in funeral practices for the fatal cases and fully recovered after combination antimicrobial therapy: intramuscular streptomycin followed by oral co-trimoxazole. The Y. pestis strain that circulated during this outbreak is resistant to streptomycin resulting from a spontaneous point mutation in the 30S ribosomal protein S12 (rpsL) gene. This same mutation causes streptomycin resistance in 2 unrelated Y. pestis strains, one isolated from a fatal PP case in a different region of Madagascar in 1987 and another isolated from a fatal PP case in China in 1996, documenting this mutation has occurred independently at least 3 times in Y. pestis. Laboratory experiments revealed this mutation has no detectable impact on fitness or virulence, and revertants to wild-type are rare in other species containing it, suggesting Y. pestis strains containing it could persist in the environment. Conclusions Unique antimicrobial resistant (AMR) strains of Y. pestis continue to arise in Madagascar and can be transmitted during PP outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Local‐scale diversity of Yersinia pestis: A case study from Ambohitromby, Ankazobe District, Madagascar.
- Author
-
Ramasindrazana, Beza, Parany, Mamionah N. J., Rasoamalala, Fanohinjanaharinirina, Rasoanoro, Mercia, Rahajandraibe, Soloandry, Vogler, Amy J., Sahl, Jason W., Andrianaivoarimanana, Voahangy, Rajerison, Minoarisoa, and Wagner, David M.
- Subjects
YERSINIA pestis ,PLAGUE ,RATTUS rattus ,RATS ,ZOONOSES ,PUBLIC health - Abstract
Plague is a re‐emerging zoonotic disease and a major public health concern in several portions of the world, especially in Madagascar. We report on the presence of different subtypes of Yersinia pestis co‐occurring in the same locality. After confirmation of a human plague case in Ambohitromby Commune (Ankazobe District) via isolation of Y. pestis, we undertook small mammal trapping to identify the circulation of Y. pestis amongst rodents in this locality; blood samples were collected from rodents for seroprevalence analysis. Of the 60 individuals of Rattus rattus captured, one yielded an isolate of Y. pestis, 13 others were positive for F1 antigen of Y. pestis using a rapid diagnostic test, and 4 were PCR positive targeting the caf1 and pla genes; 28/60 (46.7%) of the captured R. rattus were seropositive for Y. pestis. Whole‐genome SNP analyses revealed that the two isolates obtained from the human case, and the R. rattus belonged to two different subtypes of Y. pestis (s05 and s13, respectively) that were circulating concurrently in Ambohitromby in 2016. Three Y. pestis subtypes (s03, s05 and s13) have now been isolated from Ambohitromby. Subtype s05 had been persisting there for >10 years but one or both of the other subtypes may have been introduced from the Central Highlands region as they were not observed in previous years (s13) or only observed once previously (s03). High seroprevalence against Y. pestis in R. rattus suggests that a portion of the local murine population may have acquired resistance to Y. pestis. Future research should focus on genomically characterizing Y. pestis strains circulating in Ankazobe District and other plague‐endemic regions of Madagascar to better understand the overall phylogeography of Y. pestis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): A case study of bubonic plague.
- Author
-
Rasoanaivo, Tsinjo Fehizoro, Bourner, Josephine, Randriamparany, Ravaka Niaina, Gamana, Théodora Mayouya, Andrianaivoarimanana, Voahangy, Raherivelo, Mily Harijaona, Randriamampionona, Harivelo, Rajerison, Minoarisoa, Raberahona, Mihaja, Salam, Alex Paddy, Edwards, Tansy, Olliaro, Piero L., and Randremanana, Rindra Vatosoa
- Subjects
NEGLECTED diseases ,MEDICAL research ,COVID-19 pandemic ,RANDOMIZED controlled trials ,COVID-19 ,INFLUENZA - Abstract
Background: Among the many collaterals of the COVID-19 pandemic is the disruption of health services and vital clinical research. COVID-19 has magnified the challenges faced in research and threatens to slow research for urgently needed therapeutics for Neglected Tropical Diseases (NTDs) and diseases affecting the most vulnerable populations. Here we explore the impact of the pandemic on a clinical trial for plague therapeutics and strategies that have been considered to ensure research efforts continue. Methods: To understand the impact of the COVID-19 pandemic on the trial accrual rate, we documented changes in patterns of all-cause consultations that took place before and during the pandemic at health centres in two districts of the Amoron'I Mania region of Madagascar where the trial is underway. We also considered trends in plague reporting and other external factors that may have contributed to slow recruitment. Results: During the pandemic, we found a 27% decrease in consultations at the referral hospital, compared to an 11% increase at peripheral health centres, as well as an overall drop during the months of lockdown. We also found a nation-wide trend towards reduced number of reported plague cases. Discussion: COVID-19 outbreaks are unlikely to dissipate in the near future. Declining NTD case numbers recorded during the pandemic period should not be viewed in isolation or taken as a marker of things to come. It is vitally important that researchers are prepared for a rebound in cases and, most importantly, that research continues to avoid NTDs becoming even more neglected. Author summary: The COVID-19 pandemic has forced health systems to re-evaluate service provision, leading to the diversion of resources and widespread disruption of research activities. In particular, the pandemic has jeopardised the progress of research for Neglected Tropical Diseases (NTDs), which has historically faced considerable challenges. Many NTDs suffer a lack of robust clinical evidence to support current treatment recommendations and previous attempts to conduct clinical trials have been hampered by field conditions. This article presents the case of a randomised controlled trial for an NTD that was initiated at the start of the pandemic and explores the factors that may have influenced enrolment. Importantly, this article highlights mitigation strategies that have been considered by the trial team to ensure that trial activities can be maintained. The reduction in reporting of NTDs during the pandemic does not necessarily mean that there are fewer cases at the community level or that this trend will continue. As outbreaks of COVID-19 persist, strategies to mitigate the effect of continued disruption are critical to ensure that, even with a downward trend in NTD case notification, studies addressing an urgent research need can continue and NTDs don't become even more neglected than they already are. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Field assessment of dog as sentinel animal for plague in endemic foci of Madagascar.
- Author
-
RAJERISON, Minoarisoa, ANDRIANAIVOARIMANANA, Voahangy, RATSITORAHINA, Maherisoa, RAHELINIRINA, Soanandrasana, CHANTEAU, Suzanne, TELFER, Sandra, and RAHALISON, Lila
- Subjects
- *
ENDEMIC animals , *PLAGUE , *YERSINIA pestis , *CANIS , *RODENTS , *SEROCONVERSION , *CARNIVOROUS animals , *DOGS - Abstract
The epidemiology of Yersinia pestis, the causative agent of plague, involves vectors and reservoirs in its transmission cycle. The passive plague surveillance in Madagascar targets mainly rodent and fleas. However, carnivores are routinely surveyed as sentinels of local plague activity in some countries. The aim of this study is to assess the use of domestic dog (Canis familiaris) as sentinel animal for field surveillance of plague in a highly endemic area in Madagascar. Cross‐sectional surveys of plague antibody prevalence in C. familiaris were conducted in endemic areas with contrasting histories of plague cases in humans, as well as a plague free area. Rodent capture was done in parallel to evaluate evidence for Y. pestis circulation in the primary reservoirs. In 2 sites, dogs were later re‐sampled to examine evidence of seroconversion and antibody persistence. Biological samplings were performed between March 2008 and February 2009. Plague antibody detection was assessed using anti‐F1 ELISA. Our study showed a significant difference in dog prevalence rates between plague‐endemic and plague‐free areas, with no seropositive dogs detected in the plague free area. No correlation was found between rodents and dog prevalence rates, with an absence of seropositive rodents in some area where plague circulation was indicated by seropositive dogs. This is consistent with high mortality rates in rodents following infection. Re‐sampling dogs identified individuals seropositive on both occasions, indicating high rates of re‐exposure and/or persistence of plague antibodies for at least 9 months. Seroconversion or seropositive juvenile dogs indicated recent local plague circulation. In Madagascar, dog surveillance for plague antibody could be useful to identify plague circulation in new areas or quiescent areas within endemic zones. Within active endemic areas, monitoring of dog populations for seroconversion (negative to positive) or seropositive juvenile dogs could be useful for identifying areas at greatest risk of human outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Rodent control to fight plague: field assessment of methods based on rat density reduction.
- Author
-
RAHELINIRINA, Soanandrasana, SCOBIE, Kathryn, RAMASINDRAZANA, Beza, ANDRIANAIVOARIMANANA, Voahangy, RASOAMALALA, Fanohinjanaharinirina, RANDRIANTSEHENO, Lovasoa Nomena, RAKOTONIAINA, Jerry Sylvio, GORGÉ, Olivier, LAMBIN, Xavier, VALADE, Eric, TELFER, Sandra, and RAJERISON, Minoarisoa
- Subjects
RODENT control ,PLAGUE ,RATS ,MICE ,RATTUS rattus ,RODENT populations ,FOOD security - Abstract
Rodents represent a serious threat to food security and public health. The extent to which rodent control can mitigate the risk from rodent‐borne disease depends on both the effectiveness of control in reducing rodent abundance and the impact on disease epidemiology. Focusing on a plague‐endemic region of Madagascar, this study compared the effectiveness of 3 methods: live‐traps, snap‐traps, and rodenticides. Control interventions were implemented inside houses between May and October 2019. Tracking tiles monitored rodent abundance. Rodent fleas, the vector involved in plague transmission, were collected. Rodent populations consisted of Rattus rattus and Mus musculus. In terms of trap success, we found that our live‐trap regime was more effective than snap‐traps. While all 3 control strategies appeared to reduce in‐house rodent activity in the short term, we found no evidence of a longer‐term effect, with in‐house rodent abundance in treated sites comparable to non‐treatment sites by the following month. Endemic flea, Synopsyllus fonquerniei, is a key plague vector usually found on rats living outdoors. Although we found no evidence that its abundance inside houses increased following control, this may have been due to a lack of power caused by significant variation in S. fonquerniei abundance. The presence of S. fonquerniei in houses was more likely when S. fonquerniei abundance on outdoor rats was higher, which in turn correlated with high rat abundance. Our results emphasize that control strategies need to consider this connectivity between in‐house rat–flea populations and the outdoor populations, and any potential consequences for plague transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Human plague: An old scourge that needs new answers.
- Author
-
Vallès, Xavier, Stenseth, Nils Chr., Demeure, Christian, Horby, Peter, Mead, Paul S., Cabanillas, Oswaldo, Ratsitorahina, Mahery, Rajerison, Minoarisoa, Andrianaivoarimanana, Voahangy, Ramasindrazana, Beza, Pizarro-Cerda, Javier, Scholz, Holger C., Girod, Romain, Hinnebusch, B. Joseph, Vigan-Womas, Ines, Fontanet, Arnaud, Wagner, David M., Telfer, Sandra, Yazdanpanah, Yazdan, and Tortosa, Pablo
- Subjects
MERS coronavirus ,EBOLA virus disease ,ADENOVIRUS diseases ,PLAGUE ,VACCINE development - Abstract
Yersinia pestis, the bacterial causative agent of plague, remains an important threat to human health. Plague is a rodent-borne disease that has historically shown an outstanding ability to colonize and persist across different species, habitats, and environments while provoking sporadic cases, outbreaks, and deadly global epidemics among humans. Between September and November 2017, an outbreak of urban pneumonic plague was declared in Madagascar, which refocused the attention of the scientific community on this ancient human scourge. Given recent trends and plague's resilience to control in the wild, its high fatality rate in humans without early treatment, and its capacity to disrupt social and healthcare systems, human plague should be considered as a neglected threat. A workshop was held in Paris in July 2018 to review current knowledge about plague and to identify the scientific research priorities to eradicate plague as a human threat. It was concluded that an urgent commitment is needed to develop and fund a strong research agenda aiming to fill the current knowledge gaps structured around 4 main axes: (i) an improved understanding of the ecological interactions among the reservoir, vector, pathogen, and environment; (ii) human and societal responses; (iii) improved diagnostic tools and case management; and (iv) vaccine development. These axes should be cross-cutting, translational, and focused on delivering context-specific strategies. Results of this research should feed a global control and prevention strategy within a "One Health" approach. Author summary: The historical aspect of plague makes for fascinating reading, due to its capacity to disrupt human society and its socioeconomic and cultural impacts throughout human history. We argue that the Madagascar outbreak in 2017 is a tipping point in human plague epidemiology and a call to elevate research priorities on plague as a matter of some urgency. In contrast with what occurred with the Ebola virus disease crisis in West Africa between 2013 and 2015 and the new coronaviruses (the emergence of severe acute respiratory syndrome coronavirus [SARS-CoV] and Middle East respiratory syndrome coronavirus [MERS-CoV] as early warnings of the current severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] pandemic), we have an opportunity to act preventively and enable evidence-based measures to avoid major health crises due to plague outbreaks in the near future. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Development and evaluation of loop-mediated isothermal amplification for detection of Yersinia pestis in plague biological samples.
- Author
-
Randriantseheno, Lovasoa N., Rahantamalala, Anjanirina, Randrianierenana, Ando L., Rajerison, Minoarisoa, and Andrianaivoarimanana, Voahangy
- Subjects
YERSINIA pestis ,PLAGUE ,DETECTION limit ,CROSS reactions (Immunology) ,GENE targeting - Abstract
Background: Several tests are available for plague confirmation but bacteriological culture with Yersinia pestis strain isolation remains the gold standard according to the World Health Organization. However, this is a time consuming procedure; requiring specific devices and well-qualified staff. In addition, strain isolation is challenging if antibiotics have been administered prior to sampling. Here, we developed a loop-mediated isothermal amplification (LAMP) technique, a rapid, simple, sensitive and specific technique that would be able to detect Y. pestis in human biological samples. Methods: LAMP primers were designed to target the caf1 gene which is specific to Y. pestis. The detection limit was determined by testing 10-fold serial dilution of Y. pestis DNA. Cross-reactivity was tested using DNA extracts from 14 pathogens and 47 residual samples from patients suffering from non-plague diseases. Specificity and sensitivity of the LAMP caf1 were assessed on DNA extracts of 160 human biological samples. Then, the performance of the LAMP caf1 assay was compared to conventional PCR and bacteriological culture. Results: The detection limit of the developed Y. pestis LAMP assay was 3.79 pg/μl, similar to conventional PCR. The result could be read out within 45 min and as early as 35 minutes in presence of loop primer, using a simple water bath at 63°C. This is superior to culture with respect to time (requires up to 10 days) and simplicity of equipment compared to PCR. Furthermore, no cross-reactivity was found when tested on DNA extracts from other pathogens and human biological samples from patients with non-plague diseases. Compared to the gold standard, LAMP sensitivity and specificity were 97.9% (95% CI: 89.1%-99.9%) and 94.6% (95% CI: 88.6%-97.9%), respectively. Conclusion: LAMP detected Y. pestis effectively with high sensitivity and specificity in human plague biological samples. It can potentially be used in the field during outbreaks in resource limited countries such as Madagascar. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study.
- Author
-
Salam, Alex P., Raberahona, Mihaja, Andriantsalama, Prisca, Read, Liam, Andrianarintsiferantsoa, Faraniaina, Razafinambinintsoa, Tiana, Rakotomalala, Rado, Hasiniatsy, Rodrigue N. E., Razafimandimby, Dominique, Castle, Lyndsey, Funk, Anna, Mangahasimbola, Reziky T., Renaud, Bertrand, Bertherat, Eric, Lovering, Andrew, Heraud, Jean-Michel, Andrianaivoarimanana, Voahangy, Frédérique, Randrianirina, Razanajatovo, Norosoa, and Baril, Laurence
- Published
- 2020
- Full Text
- View/download PDF
23. Low cost, low tech SNP genotyping tools for resource-limited areas: Plague in Madagascar as a model.
- Author
-
Mitchell, Cedar L., Andrianaivoarimanana, Voahangy, Colman, Rebecca E., Busch, Joseph, Hornstra-O’Neill, Heidie, Keim, Paul S., Wagner, David M., Rajerison, Minoarisoa, and Birdsell, Dawn N.
- Subjects
- *
PATHOGENIC microorganisms , *SINGLE nucleotide polymorphisms , *POLYMERASE chain reaction , *GEL electrophoresis , *BIOLOGICAL reagents - Abstract
Background: Genetic analysis of pathogenic organisms is a useful tool for linking human cases together and/or to potential environmental sources. The resulting data can also provide information on evolutionary patterns within a targeted species and phenotypic traits. However, the instruments often used to generate genotyping data, such as single nucleotide polymorphisms (SNPs), can be expensive and sometimes require advanced technologies to implement. This places many genotyping tools out of reach for laboratories that do not specialize in genetic studies and/or lack the requisite financial and technological resources. To address this issue, we developed a low cost and low tech genotyping system, termed agarose-MAMA, which combines traditional PCR and agarose gel electrophoresis to target phylogenetically informative SNPs. Methodology/Principal findings: To demonstrate the utility of this approach for generating genotype data in a resource-constrained area (Madagascar), we designed an agarose-MAMA system targeting previously characterized SNPs within Yersinia pestis, the causative agent of plague. We then used this system to genetically type pathogenic strains of Y. pestis in a Malagasy laboratory not specialized in genetic studies, the Institut Pasteur de Madagascar (IPM). We conducted rigorous assay performance validations to assess potential variation introduced by differing research facilities, reagents, and personnel and found no difference in SNP genotyping results. These agarose-MAMA PCR assays are currently employed as an investigative tool at IPM, providing Malagasy researchers a means to improve the value of their plague epidemiological investigations by linking outbreaks to potential sources through genetic characterization of isolates and to improve understanding of disease ecology that may contribute to a long-term control effort. Conclusions: The success of our study demonstrates that the SNP-based genotyping capacity of laboratories in developing countries can be expanded with manageable financial cost for resource constraint laboratories. This is a practical formula that reduces resource-driven limitations to genetic research and promises to advance global collective knowledge of infectious diseases emanating from resource limited regions of the world. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. Temporal phylogeography of Yersinia pestis in Madagascar: Insights into the long-term maintenance of plague.
- Author
-
Vogler, Amy J., Andrianaivoarimanana, Voahangy, Telfer, Sandra, Hall, Carina M., Sahl, Jason W., Hepp, Crystal M., Centner, Heather, Andersen, Genevieve, Birdsell, Dawn N., Rahalison, Lila, Nottingham, Roxanne, Keim, Paul, Wagner, David M., and Rajerison, Minoarisoa
- Subjects
- *
YERSINIA pestis , *PLAGUE , *COMMUNICABLE diseases , *GENOMES , *PHYLOGENY - Abstract
Background: Yersinia pestis appears to be maintained in multiple, geographically separate, and phylogenetically distinct subpopulations within the highlands of Madagascar. However, the dynamics of these locally differentiated subpopulations through time are mostly unknown. To address that gap and further inform our understanding of plague epidemiology, we investigated the phylogeography of Y. pestis in Madagascar over an 18 year period. Methodology/Principal findings: We generated whole genome sequences for 31 strains and discovered new SNPs that we used in conjunction with previously identified SNPs and variable-number tandem repeats (VNTRs) to genotype 773 Malagasy Y. pestis samples from 1995 to 2012. We mapped the locations where samples were obtained on a fine geographic scale to examine phylogeographic patterns through time. We identified 18 geographically separate and phylogenetically distinct subpopulations that display spatial and temporal stability, persisting in the same locations over a period of almost two decades. We found that geographic areas with higher levels of topographical relief are associated with greater levels of phylogenetic diversity and that sampling frequency can vary considerably among subpopulations and from year to year. We also found evidence of various Y. pestis dispersal events, including over long distances, but no evidence that any dispersal events resulted in successful establishment of a transferred genotype in a new location during the examined time period. Conclusions/Significance: Our analysis suggests that persistent endemic cycles of Y. pestis transmission within local areas are responsible for the long term maintenance of plague in Madagascar, rather than repeated episodes of wide scale epidemic spread. Landscape likely plays a role in maintaining Y. pestis subpopulations in Madagascar, with increased topographical relief associated with increased levels of localized differentiation. Local ecological factors likely affect the dynamics of individual subpopulations and the associated likelihood of observing human plague cases in a given year in a particular location. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
25. Diverse Genotypes of Yersinia pestis Caused Plague in Madagascar in 2007.
- Author
-
Riehm, Julia M., Projahn, Michaela, Vogler, Amy J., Rajerison, Minoaerisoa, Andersen, Genevieve, Hall, Carina M., Zimmermann, Thomas, Soanandrasana, Rahelinirina, Andrianaivoarimanana, Voahangy, Straubinger, Reinhard K., Nottingham, Roxanne, Keim, Paul, Wagner, David M., and Scholz, Holger C.
- Subjects
YERSINIA pestis ,SINGLE nucleotide polymorphisms ,TANDEM repeats ,GENOTYPES ,MOLECULAR epidemiology - Abstract
Background: Yersinia pestis is the causative agent of human plague and is endemic in various African, Asian and American countries. In Madagascar, the disease represents a significant public health problem with hundreds of human cases a year. Unfortunately, poor infrastructure makes outbreak investigations challenging. Methodology/Principal Findings: DNA was extracted directly from 93 clinical samples from patients with a clinical diagnosis of plague in Madagascar in 2007. The extracted DNAs were then genotyped using three molecular genotyping methods, including, single nucleotide polymorphism (SNP) typing, multi-locus variable-number tandem repeat analysis (MLVA), and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) analysis. These methods provided increasing resolution, respectively. The results of these analyses revealed that, in 2007, ten molecular groups, two newly described here and eight previously identified, were responsible for causing human plague in geographically distinct areas of Madagascar. Conclusions/Significance: Plague in Madagascar is caused by numerous distinct types of Y. pestis. Genotyping method choice should be based upon the discriminatory power needed, expense, and available data for any desired comparisons. We conclude that genotyping should be a standard tool used in epidemiological investigations of plague outbreaks. Author Summary: Yersinia pestis is a highly pathogenic bacterium and the causative agent of human plague. It has caused three recognized pandemics and is a current human health problem in many countries of Africa, Asia and the Americas, including Madagascar. The pathogen cannot be eradicated from natural plague foci as it persists in various known and cryptic rodent reservoir species. Genotyping is a critical tool in understanding the molecular epidemiology and possible kinetics of plague. In the present study, we succeeded in extracting DNA and genotyping directly from human clinical samples from Madagascar. We applied three different methods, including single nucleotide polymorphism (SNP) typing, multi-locus variable-number tandem repeat (VNTR) analysis (MLVA), and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) analysis. Relative to their discriminatory power, all three methods provided important genotype information useful for understanding the molecular epidemiology of the disease, revealing that multiple, distinct genotypes caused human plague in Madagascar within one year, 2007. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
26. Die Pest, eine immer noch gefürchtete Infektionskrankheit.
- Author
-
Riehm, Julia M., Rajerison, Minoarisoa, Andrianaivoarimanana, Voahangy, and Scholz, Holger C.
- Published
- 2014
- Full Text
- View/download PDF
27. Understanding the Persistence of Plague Foci in Madagascar.
- Author
-
Andrianaivoarimanana, Voahangy, Kreppel, Katharina, Elissa, Nohal, Duplantier, Jean-Marc, Carniel, Elisabeth, Rajerison, Minoarisoa, and Jambou, Ronan
- Subjects
- *
RATTUS rattus , *RODENT populations , *YERSINIA pestis , *HUMAN behavior , *POPULATION dynamics - Abstract
Plague, a zoonosis caused by Yersinia pestis, is still found in Africa, Asia, and the Americas. Madagascar reports almost one third of the cases worldwide. Y. pestis can be encountered in three very different types of foci: urban, rural, and sylvatic. Flea vector and wild rodent host population dynamics are tightly correlated with modulation of climatic conditions, an association that could be crucial for both the maintenance of foci and human plague epidemics. The black rat Rattus rattus, the main host of Y. pestis in Madagascar, is found to exhibit high resistance to plague in endemic areas, opposing the concept of high mortality rates among rats exposed to the infection. Also, endemic fleas could play an essential role in maintenance of the foci. This review discusses recent advances in the understanding of the role of these factors as well as human behavior in the persistence of plague in Madagascar. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
28. Immune Responses to Plague Infection in Wild Rattus rattus, in Madagascar: A Role in Foci Persistence?
- Author
-
Andrianaivoarimanana, Voahangy, Telfer, Sandra, Rajerison, Minoarisoa, Ranjalahy, Michel A., Andriamiarimanana, Fehivola, Rahaingosoamamitiana, Corinne, Rahalison, Lila, and Jambou, Ronan
- Subjects
- *
IMMUNE response , *PLAGUE , *IMMUNOLOGY , *IMMUNOGLOBULIN M , *PUBLIC health , *CITIES & towns , *MEDICAL sciences - Abstract
Background: Plague is endemic within the central highlands of Madagascar, where its main reservoir is the black rat, Rattus rattus. Typically this species is considered susceptible to plague, rapidly dying after infection inducing the spread of infected fleas and, therefore, dissemination of the disease to humans. However, persistence of transmission foci in the same area from year to year, supposes mechanisms of maintenance among which rat immune responses could play a major role. Immunity against plague and subsequent rat survival could play an important role in the stabilization of the foci. In this study, we aimed to investigate serological responses to plague in wild black rats from endemic areas of Madagascar. In addition, we evaluate the use of a recently developed rapid serological diagnostic test to investigate the immune response of potential reservoir hosts in plague foci. Methodology/Principal Findings: We experimentally infected wild rats with Yersinia pestis to investigate short and longterm antibody responses. Anti-F1 IgM and IgG were detected to evaluate this antibody response. High levels of anti-F1 IgM and IgG were found in rats one and three weeks respectively after challenge, with responses greatly differing between villages. Plateau in anti-F1 IgM and IgG responses were reached for as few as 500 and 1500 colony forming units (cfu) inoculated respectively. More than 10% of rats were able to maintain anti-F1 responses for more than one year. This anti-F1 response was conveniently followed using dipsticks. Conclusion/Significance: Inoculation of very few bacteria is sufficient to induce high immune response in wild rats, allowing their survival after infection. A great heterogeneity of rat immune responses was found within and between villages which could heavily impact on plague epidemiology. In addition, results indicate that, in the field, anti-F1 dipsticks are efficient to investigate plague outbreaks several months after transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
29. Development and Evaluation of Two Simple, Rapid Immunochromatographic Tests for the Detection of Yersinia pestis Antibodies in Humans and Reservoirs.
- Author
-
Rajerison, Minoarisoa, Dartevelle, Sylvie, Ralafiarisoa, Lalao A., Bitam, Idir, Tuyet, Dinh Thi Ngoc, Andrianaivoarimanana, Voahangy, Nato, Faridabano, and Rahalison, Lila
- Subjects
YERSINIA pestis ,ANTIGEN analysis ,IMMUNOGLOBULINS ,SERODIAGNOSIS ,SYMPTOMS - Abstract
Background: Tools for plague diagnosis and surveillance are not always available and affordable in most of the countries affected by the disease. Yersinia pestis isolation for confirmation is time-consuming and difficult to perform under field conditions. Serologic tests like ELISA require specific equipments not always available in developing countries. In addition to the existing rapid test for antigen detection, a rapid serodiagnostic assay may be useful for plague control. Methods/Principal Findings: We developed two rapid immunochromatography-based tests for the detection of antibodies directed against F1 antigen of Y. pestis. The first test, SIgT, which detects total Ig (IgT) anti-F1 in several species (S) (human and reservoirs), was developed in order to have for the field use an alternative method to ELISA. The performance of the SIgT test was evaluated with samples from humans and animals for which ELISA was used to determine the presumptive diagnosis of plague. SIgT test detected anti-F1 Ig antibodies in humans with a sensitivity of 84.6% (95% CI: 0.76–0.94) and a specificity of 98% (95% CI: 0.96–1). In evaluation of samples from rodents and other small mammals, the SlgT test had a sensitivity of 87.8% (95% CI: 0.80–0.94) and a specificity of 90.3% (95% CI: 0.86–0.93). Improved performance was obtained with samples from dogs, a sentinel animal, with a sensitivity of 93% (95% CI: 0.82–1) and a specificity of 98% (95% CI: 0.95–1.01). The second test, HIgM, which detects human (H) IgM anti-F1, was developed in order to have another method for plague diagnosis. Its sensitivity was 83% (95% CI: 0.75–0.90) and its specificity about 100%. Conclusion/Significance: The SIgT test is of importance for surveillance because it can detect Ig antibodies in a range of reservoir species. The HIgM test could facilitate the diagnosis of plague during outbreaks, particularly when only a single serum sample is available. Author Summary: Plague is due to the bacterium Yersinia pestis. It is accidentally transmitted to humans by the bite of infected fleas. Currently, approximately 20 developing countries with very limited infrastructure are still affected. A plague case was defined according to clinical, epidemiological and biological features. Rapid diagnosis and surveillance of the disease are essential for its control. Indeed, the delay of treatment is often rapidly fatal for patients and outbreaks may occur. Bubo aspirate is the most appropriate specimen in case of bubonic plague, but its collection is not always feasible. The main current biological approaches for the diagnosis of human plague are F1 antigen detection, serology for antibody detection by ELISA and Y. pestis isolation. The biological diagnosis of plague remains a challenge because the clinical signs are not specific. In this study, we developed some simple, rapid and affordable tests able to detect specific plague antibodies. These tests can be used as alternative methods for plague diagnosis in the field and for plague surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
30. Exposure to Yersinia pestis increases resistance to plague in black rats and modulates transmission in Madagascar.
- Author
-
Andrianaivoarimanana, Voahangy, Rajerison, Minoarisoa, and Jambou, Ronan
- Subjects
- *
YERSINIA pestis , *PLAGUE , *YERSINIA diseases , *RATS as carriers of disease , *EPIDEMICS - Abstract
Objectives: In Madagascar, plague (Yersinia pestis infection) is endemic in the central highlands, maintained by the couple Rattus rattus/flea. The rat is assumed to die shortly after infection inducing migration of the fleas. However we previously reported that black rats from endemic areas can survive the infection whereas those from non-endemic areas remained susceptible. We investigate the hypothesis that lineages of rats can acquire resistance to plague and that previous contacts with the bacteria will affect their survival, allowing maintenance of infected fleas. For this purpose, laboratory-born rats were obtained from wild black rats originating either from plague-endemic or plague-free zones, and were challenged with Y. pestis. Survival rate and antibody immune responses were analyzed. Results: Inoculation of low doses of Y. pestis greatly increase survival of rats to subsequent challenge with a lethal dose. During challenge, cytokine profiles support activation of specific immune response associated with the bacteria control. In addition, F1 rats from endemic areas exhibited higher survival rates than those from non-endemic ones, suggesting a selection of a resistant lineage. In Madagascar, these results support the role of black rat as long term reservoir of infected fleas supporting maintenance of plague transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.